author-photo

Sandra J. Horning

Stanford University

221

Papers

25744

Citations

Citation Trend

Filter By

Papers (221) Sort By

Journal Conference Others

Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab

2019 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (6)
Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499

2017 Leukemia
Show All
- Source
- Cite
- Save
Citations (11)
A subgroup analysis of small lymphocytic and marginal zone lymphomas in the Eastern Cooperative Oncology Group protocol E4402 (RESORT): A randomized phase III study comparing two different rituximab dosing strategies for low tumor burden indolent non-Hodgkin lymphoma.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (6)
Plasma viral DNA as a marker of tumor response in EBV(+) Hodgkin lymphoma in a phase III study (E2496).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Serum Biomarkers Predict Outcomes in Advanced Hodgkin Lymphoma Independent of International Prognostic Score (IPS) and Treatment: Correlative Analysis from a Large North American Cooperative Group Trial

2016 Blood
Show All
- Source
- Cite
- Save
Citations (3)
Complete remissions with weekly dosing of SGN-35, a novel antibody-drug conjugate (ADC) targeting CD30, in a phase I dose-escalation study in patients with relapsed or refractory Hodgkin lymphoma (HL) or systemic anaplastic large cell lymphoma (sALCL)

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (30)
Response‐adapted therapy for aggressive non‐Hodgkin's lymphomas based on early [18F] FDG‐PET scanning: ECOG‐ACRIN Cancer Research Group study (E3404)

2015 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (35)
A phase II trial of RCHOP followed by radioimmunotherapy for early stage (stages I/II) diffuse large B-cell non-Hodgkin lymphoma: ECOG3402

2015 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (17)
Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (19)
Mature Results of a Phase II Study of Rituximab Therapy for Nodular Lymphocyte–Predominant Hodgkin Lymphoma

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (80)